INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 35.64 Billion By 2029 | 8.25% | North America |
| By Product | By Type | By End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Cell-based Assay Market Overview
The Cell-Based Assay Market Is Expected to Grow At 8.25% CAGR From 2022 To 2029. It Is Expected to Reach Above USD 35.64 Billion By 2029 From USD 18.9 Billion In 2021.
A scientific method called a cell-based assay is used to assess how different substances affect living cells. The biological activity, toxicity, or effectiveness of a drug, chemical compound, or experimental treatment is evaluated using cultured cells as a model system. In a cell-based assay, cells are developed in a setting that as closely resembles their natural surroundings as possible. These cells may be created from cell lines specifically created for research or they may be derived from human or animal tissues. The substance of interest, which may be a drug candidate, a potential environmental toxin, or a therapeutic agent, is applied to the cells.
By monitoring various factors like cell viability, proliferation, apoptosis (programmed cell death), or the activity of particular molecular pathways, researchers can analyses how the substance affects the way the cells react. This information aids in determining the effect of the substance on cellular function and offers important insights into its mode of action. Drug discovery, toxicology research, and fundamental biological studies all frequently employ cell-based assays. They provide a more accurate representation of the intricate interactions taking place within living organisms, which gives them a number of advantages over conventional biochemical assays. These assays can also be scaled up and automated, enabling high-throughput screening of sizable compound libraries.
In conclusion, cell-based assays are crucial tools in biomedical research because they let researchers assess how different compounds affect cellular processes, which helps them better understand how diseases work and pave the way for the creation of novel treatments.
Numerous public and private organizations have significantly increased their R&D funding in order to create better and safer medications. Additionally, technological developments in cell-based assays have made it possible for researchers to begin utilizing this technology for toxicology and drug discovery studies. The rising incidence of lifestyle diseases like arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc., which still have significant unmet needs and have prompted continuous investments in R&D, is another important factor driving the market’s expansion. This market is also being driven by an increase in the use of cell-based assay techniques for high throughput screening methods like toxicity studies, drug screening, in vitro testing, etc.
The market for cell-based assays may be impacted by a number of constraints. First of all, the high cost of cell-based assay systems, including hardware, chemicals, and maintenance, may prevent their widespread use, especially in smaller research institutions with tighter budgets. Additionally, some laboratories may find it difficult to implement cell-based assays due to the complexity of these tests, which call for specialized personnel and training. Additionally, a lack of standardization in assay procedures and cell lines can result in variability and impair the reproducibility of results. The potential for false-positive or false-negative results as well as ethical concerns regarding the use of animal-derived cells can also have an impact on the market’s expansion.
Growing populations and economies in developing nations like China and India are anticipated to drive market expansion for cell-based assays. Additionally, the development of new technologies such as 3D cell-based assays, sophisticated detection techniques, growing demand for toxicity screening, and expanded uses for cell-based assays are anticipated to present new opportunities for the global market for cell-based assays.
The COVID-19 pandemic had a favorable effect on the market for cell-based assays. A variety of cell-based trials in viral infection research, vaccine development, and all-encompassing drug discovery have been made possible by the increased demand for Covid-19 research. But it is also used to speed up throughput, cut down on time, and give an early warning of any toxic properties, which has significantly increased the demand for cell-based assay.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), Value (thousand units) |
| Segmentation | By product, By type, By end user, By Region |
| By Product |
|
| By Type |
|
| By End User |
|
| By Region
 |
|
Cell-based Assay Market Segment Analysis
The cell-based assay market is segmented based on product, type, end user and region. By product market is segmented into consumable, cell lines, microplates, probes & labels, and instruments & software. Consumable is further sub-segmented into reagents and assay kits. Cell line is further sub-segmented into immortalized cell lines, primary cell lines, and stem cell lines. By type market is segmented into drug discovery, basic research, ADME studies, predictive toxicology, others. By end user market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, and contract research organizations.
Due to widespread consumption of consumable products and widespread use by biopharma and biotech firms for the development and production of cells, particularly in an emerging market, the consumable market segment had the highest revenue share in 2021. Additionally, over the course of the forecast period, market growth is anticipated to be complemented by the growing demand for the development of therapeutic research activities.
The market share leader and anticipated to grow at the highest CAGR during the forecast period is the drug discovery segment. The factors driving the segment’s expansion are linked to increase R&D spending by biopharmaceutical firms. Moreover, the demand for cell-based assays for more recent drug discoveries is being fueled by the rise in chronic diseases like cancer, osteoarthritis, cardiovascular diseases, and diabetes.
For the forecast period, the Pharmaceutical & Biotechnology Companies segment is anticipated to experience the highest CAGR. Due to their numerous advantages, cell-based assays are increasingly in demand among pharmaceutical and biotechnology companies, which is what is responsible for the segment’s growth. In the pharmaceutical industry, cell-based assays are useful for figuring out how environmental cues or pharmacological agents affect cellular activity in general.
Cell-based Assay Market Players
The Cell-Based Assay Market key players include BD, Bio-Rad Laboratories Inc., Corning Inc., Charles River Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd. (Roche Holdings AG), Lonza, Merck KGaA, Promega Corp., Thermo Fisher Scientific Inc., and others.
Recent Developments:
- 18 October 2022: BD (Becton, Dickinson and Company) (NYSE: BDX), announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.
- 04 May 2023: Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the Institute of Human Biology (IHB) focusing on advancing research in the field of human model systems such as organoids.
Who Should Buy? Or Key Stakeholders
- Manufacturers
- Healthcare Sector
- End users companies
- Government organizations
- Research organizations
- Investment research firms
- Others
Cell-based Assay Market Regional Analysis
The cell-based assay market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico, Rest of North America
- Asia Pacific: includes China, Japan, South Korea, India, Australia, and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Russia, Spain, and Rest of Europe
- South America: includes Brazil, Argentina, Colombia and Rest of South America
- Middle East & Africa: includes UAE, Saudi Arabia, South Africa, and Rest of MEA
Due to the developed healthcare industry and widespread use of cell-based assays, North America currently holds the largest market share globally. Chronic diseases like cancer, osteoarthritis, and diabetes are becoming more common in the United States, which is boosting demand for cell-based assays for newer drug discoveries and contributing to the expansion of this market. For example, according to the American Cancer Society’s Cancer Facts & Figures 2022 data, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.
Similar to this, the American Heart Association stated in January 2022 that someone will experience a myocardial infarction in the United States every 40 seconds on average. The prevalence of chronic diseases in the American population is expected to fuel market expansion over the course of the forecast period.
Key Market Segments: Cell-based Assay Market
Cell-based Assay Market By Product, 2020-2029, (USD Billion, Thousand Units)
- Consumables
- Reagents
- Assay Kits
- Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Instruments & Software
Cell-based Assay Market By Type , 2020-2029, (USD Billion, Thousand Units)
- Drug Discovery
- Basic Research
- ADME Studies
- Predictive Toxicology
- Others
Cell-based Assay Market By End User, 2020-2029, (USD Billion, Thousand Units)
- Pharmaceutical And Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Cell-based Assay Market By Region, 2020-2029, (USD Billion, Thousand Units)
- North America
- Asia Pacific
- Europe
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Services Key Objectives
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the cell-based assay market over the next 7 years?
- What are the end user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as asia-pacific, middle east, and Africa?
- How is the economic environment affecting the cell-based assay market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the cell-based assay market?
- What is the current and forecasted size and growth rate of the global cell-based assay market?
- What are the key drivers of growth in the cell-based assay market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the cell-based assay market?
- What are the technological advancements and innovations in the cell-based assay market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the cell-based assay market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the cell-based assay market?
- What are the service offerings and specifications of leading players in the market?
- What is the pricing trend of cell-based assay in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL CELL-BASED ASSAY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON CELL-BASED ASSAY MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL CELL-BASED ASSAY MARKET OUTLOOK
- GLOBAL CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION, THOUSAND UNITS), 2020-2029
- CONSUMABLES
- REAGENTS
- ASSAY KITS
- CELL LINES
- IMMORTALIZED CELL LINES
- PRIMARY CELL LINES
- STEM CELL LINES
- MICROPLATES
- PROBES & LABELS
- INSTRUMENTS & SOFTWARE
- CONSUMABLES
- GLOBAL CELL-BASED ASSAY MARKET BY TYPE (USD BILLION, THOUSAND UNITS),2020-2029
- DRUG DISCOVERY
- BASIC RESEARCH
- ADME STUDIES
- PREDICTIVE TOXICOLOGY
- OTHERS
- GLOBAL CELL-BASED ASSAY MARKET BY END USER (USD BILLION, THOUSAND UNITS),2020-2029
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- ACADEMIC & RESEARCH INSTITUTES
- CONTRACT RESEARCH ORGANIZATIONS
- GLOBAL CELL-BASED ASSAY MARKET BY REGION (USD BILLION, THOUSAND UNITS),2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- REST OF NORTH AMERICA
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- BD
- BIO-RAD LABORATORIES, INC.
- CORNING INC.
- CHARLES RIVER LABORATORIES
- DANAHER CORP.
- HOFFMANN-LA ROCHE LTD. (ROCHE HOLDINGS AG)
- LONZA
- MERCK KGAA
- PROMEGA CORP.
- THERMO FISHER SCIENTIFIC INC.*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY REGION (USD BILLION), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY REGION (THOUSAND UNITS), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 10Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 11Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 12Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 13Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 14Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 15Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 16Â Â Â Â Â Â Â NORTH AMERICA CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 17Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 18Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 19Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 20Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 21Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 22Â Â Â Â Â Â Â US CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 23Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY PRODUCT (BILLION), 2020-2029
TABLE 24Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 25Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 26Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 27Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 28Â Â Â Â Â Â Â CANADA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 29Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 30Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 31Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 32Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 33Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 34Â Â Â Â Â Â Â MEXICO CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 35Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 36Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 37Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 38Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 39Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 40Â Â Â Â Â Â Â REST OF NORTH AMERICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 41Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 42Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 43Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 44Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 45Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 46Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 47Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 48Â Â Â Â Â Â Â SOUTH AMERICA CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 49Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 50Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 51Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 52Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 53Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 54Â Â Â Â Â Â Â BRAZIL CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 55Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 56Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 57Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 58Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 59Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 60Â Â Â Â Â Â Â ARGENTINA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 61Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 62Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 63Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 64Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 65Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 66Â Â Â Â Â Â Â COLOMBIA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 67Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 68Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 69Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 70Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 71Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 72Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 73Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 74Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 75Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 76Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 77Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 78Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 79Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 80Â Â Â Â Â Â Â ASIA -PACIFIC CELL-BASED ASSAY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 81Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 82Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 83Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 84Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 85Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 86Â Â Â Â Â Â Â INDIA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 87Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 88Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 89Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 90Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 91Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 92Â Â Â Â Â Â Â CHINA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 93Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 94Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 95Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 96Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 97Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 98Â Â Â Â Â Â Â JAPAN CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 99Â Â Â Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 100Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 101Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 102Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 103Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 104Â Â Â Â SOUTH KOREA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 105Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 106Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY TYPEBY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 107Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 108Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 109Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 110Â Â Â Â AUSTRALIA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 111Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 112Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY TYPEBY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 113Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 114Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 115Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 116Â Â Â Â REST OF ASIA PACIFIC CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 117Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 118Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 119Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 120Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 121Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 122Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 123Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 124Â Â Â Â EUROPE CELL-BASED ASSAY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 125Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 126Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 127Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 128Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 129Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 130Â Â Â Â GERMANY CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 131Â Â Â Â UK CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 132Â Â Â Â UK CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 133Â Â Â Â UK CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 134Â Â Â Â UK CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 135Â Â Â Â UK CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 136Â Â Â Â UK CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 137Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 138Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 139Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 140Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 141Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 142Â Â Â Â FRANCE CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 143Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 144Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 145Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 146Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 147Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 148Â Â Â Â ITALY CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 149Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 150Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 151Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 152Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 153Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 154Â Â Â Â SPAIN CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 155Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 156Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 157Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 158Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 159Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 160Â Â Â Â RUSSIA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 161Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 162Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 163Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 164Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 165Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 166Â Â Â Â REST OF EUROPE CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 167Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 168Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 169Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 170Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 171Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 172Â Â Â Â MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 173Â Â Â Â MIDDLE EAST ABD AFRICA CELL-BASED ASSAY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 174Â Â Â Â MIDDLE EAST ABD AFRICA CELL-BASED ASSAY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 175Â Â Â Â UAE CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 176Â Â Â Â UAE CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 177Â Â Â Â UAE CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 178Â Â Â Â UAE CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 179Â Â Â Â UAE CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 180Â Â Â Â UAE CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 181Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 182Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 183Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 184Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 185Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 186Â Â Â Â SAUDI ARABIA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 187Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 188Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 189Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 190Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 191Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 192Â Â Â Â SOUTH AFRICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 193Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 194Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 195Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY TYPE (USD BILLION), 2020-2029
TABLE 196Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY TYPE (THOUSAND UNITS), 2020-2029
TABLE 197Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY END USER (USD BILLION), 2020-2029
TABLE 198Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL-BASED ASSAY MARKET BY END USER (THOUSAND UNITS), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY PRODUCT, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY TYPE, USD BILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY END USER, USD BILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY PRODUCT, USD BILLION, 2021
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY TYPE, USD BILLION, 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY END USER, USD BILLION, 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL CELL-BASED ASSAY MARKET BY REGION, USD BILLION, 2021
FIGURE 17Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â Â Â Â Â Â Â Â Â BD: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â CORNING INC.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â DANAHER CORP.: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â LONZA: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â MERCK KGAA: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â PROMEGA CORP.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FAQ
Cell-based assay market was valued at USD 20.46 billion in 2022 and is projected to reach USD 35.64 billion by 2029, growing at a CAGR of 8.25% from 2022 to 2029.
Key factors that are driving the market growth includes growing demand for drug discovery, rising need for research in biotechnology, increasing incidence of infectious diseases, cancer, autoimmune, and genetic disorders.
The major players include BD, Bio-Rad Laboratories, Inc., Corning Inc., Charles River Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd. (Roche Holdings AG), Lonza, Merck KGaA, Promega Corp., Thermo Fisher Scientific Inc.
The global cell-based assay market is segmented on the basis of product, type, end user and geography.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.